, Tracking Stock Market Picks
Enter Symbol:
Dendreon Corporation (DNDN) [hlAlert]

down 75.75 %

Dendreon Corporation (DNDN) upgraded to Buy by Merriman Curhan Ford

Posted on: Wednesday,  Apr 22, 2009  8:25 AM ET by Merriman Curhan Ford

Merriman Curhan Ford rated Buy Dendreon Corporation (NASDAQ: DNDN) on 04/22/2009. Previously Merriman Curhan Ford rated Sell Dendreon Corporation (NASDAQ: DNDN) on
10/16/2008., when the stock price was $4.96. Since then, Dendreon Corporation has gained 312.50% as of 04/22/2009's recent price of $20.46.
If you would have followed the previous Merriman Curhan Ford's recommendation on DNDN, you would have lost 75.75% of your investment in 188 days.

Dendreon Corporation discovers and develops immunologically based therapeutic products for the treatment of cancer. Through the use of antigen engineering and proprietary cell separation technologies, Dendreon develops therapeutic vaccines that induce cell-mediated immunity, the body's key defense against cancer. In addition to its products for cancer, Dendreon also intends to pursue the application of its technologies in the fields of autoimmune diseases, allergies and infectious diseases.

We occupy a unique niche among our investment banking peers: we offer our clients both traditional sell-side equity research and primary market research, and we focus on high-potential sectors such as CleanTech, Consumer/Internet/Media, Health Care and Tech/Telecom. Our institutional and corporate clients get the best of both worlds: expertise from our analysts and access to experts through our Panel Intelligence platform.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/22/2009 8:25 AM Buy
as of 12/31/2009
1 Week up  32.46 %
1 Month up  28.20 %
3 Months up  25.22 %
1 YTD down  -275.42 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/16/2008 8:25 AM Sell

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy